Analysts' Actions: AMZN, C, BX, ADM, XOM

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Archer-Daniels-Midland upgraded at BMO to Outperform. $35 price target. Fundamentals should bottom out in the first quarter.

Broadcom downgraded at Auriga from Buy to Hold, Auriga USA said. Valuation call, based on a $37 price target.

Black Box Corporation downgraded to hold at TheStreet Ratings

Blackstone rated new Buy at Deutsche Bank. $19 price target. Company is a leader and can generate healthy growth.

Citigroup upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Estimates also boosted, given better operating leverage.

Eagle Materials downgraded at Jefferies to Hold from Buy, Jefferies said. $27 price target. Rating lowered on robust valuation.

First Horizon upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Company trades at a 40% discount to its peers and can likely buy back more stock.

Health Care Realty downgraded at UBS to Sell from Neutral, UBS said. $16 price target. Recent rally is overdone.

Mattel downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call.

Newmont Mining downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Company can yield more, but at the expense of growth.

Seagate Technology upgraded at Stifel from Hold to Buy, Stifel Nicolaus said. $35 price target. Company should continue to outperform.

Seagate Technology upgraded to buy at TheStreet Ratings.

Stryker downgraded at BMO from Outperform to Market Perform, BMO Capital said. Valuation call, as the stock is up 27% since August. $58 price target.

Techne downgraded at Baird from Outperform to Neutral, Robert Baird said. $71. Company is seeing slower organic revenue growth and is being hurt by the stronger dollar.

T. Rowe Price downgraded at Citigroup to Sell from Neutral, Citigroup said. $50 price target. Premium valuation is not sustainable.

T. Rowe Price downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $54 price target.

Waddell & Reed downgraded at Citigroup to Sell from Neutral, Citigroup said. $24 price target. Disappointing 4Q.

Exxon Mobil downgraded at Argus from Buy to Hold, Argus Research said. Production mix is moving toward natural gas.

Zimmer downgraded at UBS to Neutral from Sell, UBS said. $64 price target. Valuation call.

STOCK COMMENTS / EPS CHANGES

Amerigroup target raised at Oppenheimer. Shares of AGP now seen reaching $73, Oppenheimer said. Target raised to be in line with historical multiple. Outperform rating.

AMC Networks numbers raised at Morgan Stanley. Shares of AMCX now seen reaching $40, according to Morgan Stanley. Estimates also increased, given higher expected advertising growth. Underweight rating.

Affiliated Managers numbers boosted at Goldman. Shares of AMG now seen reaching $94, according to Goldman Sachs. Estimates also upped, to match the company's new guidance. Neutral rating.

Amazon.com numbers reduced at Goldman. Shares of AMZN now seen reaching $182, according to Goldman Sachs. Estimates also cut, as the company is realizing lower sales and higher costs. Neutral rating.

Amazon.com target lowered at Jefferies. Shares of AMZN now seen reaching $225, Jefferies said. Estimates also lowered on poor earnings result. Buy rating.

Amazon.com numbers lowered at Oppenheimer. Shares of AMZN now seen reaching $234, Oppenheimer said. Estimates also lowered on fourth quarter miss. Outperform rating.

C.R. Bard target raised at Jefferies to $104, Jefferies said. Still managing EPS in tough times. Buy rating.

CH Robinson Worldwide numbers lowered at Jefferies. Shares of CHRW now seen reaching $66, Jefferies said. Estimates also lowered on minimal market opportunities. Hold rating.

Cytec estimates, target boosted at Keybanc. Shares of CYT now seen reaching $64, according to Keybanc. Estimates also upped, given the company's new guidance. Buy rating.

Danaher estimates, target raised at Goldman. Shares of DHR now seen reaching $58, according to Goldman Sachs. Estimates also increased, as the company is realizing higher margins. Neutral rating.

Entergy estimates, target lowered at BMO through 2013, BMO Capital said. Company is facing rising pension costs and buying back less stock. Market Perform rating and new $69 price target.

Illinois Tool numbers increased at Goldman. ITW estimates were raised through 2013, Goldman Sachs said. Company is realizing higher organic sales growth. Sell rating and new $56 price target.

L-3 Communications numbers boosted at Credit Suisse. Shares of LLL now seen reaching $75, according to Credit Suisse. Estimates also upped, given better defense budget visibility. Neutral rating.

Mattel estimates, target increased at Goldman. MAT estimates were raised through 2013, Goldman Sachs said. HIT Entertainment acquisition should add to earnings. Neutral rating and new $33 price target.

Oshkosk estimates, target upped at Credit Suisse. OSK estimates were boosted through 2014, Credit Suisse said. AWP is at the beginning of a multi-year cycle. Neutral rating and new $27 price target.

Paccar estimates, target raised at Goldman. Shares of PCAR now seen reaching $47, according to Goldman Sachs. Estimates also increased, given higher domestic truck demand. Neutral rating.

Parexel estimates, target upped at Goldman. PRXL estimates were boosted through 2014, Goldman Sachs said. Higher sales are driving margin expansion. Sell rating and new $19 price target.

Seagate Technology numbers increased at BMO. STX estimates were raised through 2013, BMO Capital said. Company is realizing higher margins and buying back more stock. Market Perform rating and new $27 price target.

Triumph Group numbers raised at Oppenheimer. Shares of TGI now seen reaching $70, Oppenheimer said. Estimates also raised on growing margins. Outperform rating.

UPS numbers raised at Jefferies. Shares of UPS now seen reaching $82, Jefferies said. Estimates also raised on strong quarterly performance. Hold rating.

Valero estimates, target reduced at Credit Suisse. Shares of VLO now seen reaching $37, according to Credit Suisse. Estimates also cut, given a lower realized capture rate. Outperform rating.

Vertex Pharmaceuticals numbers raised at Credit Suisse. Shares of VRTX now seen reaching $42, according to Credit Suisse. Estimates also increased, following the FDA approval of Kalydeco. Outperform rating.

United States Steel numbers raised at UBS. Shares of X now seen reaching $38, according to UBS. Estimates also increased on Serbia sale and positive flow through from tubular pricing. Buy rating.

Yum! Brands estimates, target raised at UBS. Shares of YUM now seen reaching $76, according to UBS. Estimates also increased on positive sales momentum in China. Buy rating.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.